GMOVGMO U.S. Value ETF
Seeks total return by investing primarily in U.S. value equities.
By GMO · Launched 2024
Annual Cost
0.50%
#2,667 of 5,861 · average
Fund Size
$90M
#3,095 of 5,861 · mid-size
Return (1Y)Goal
+27.2%
Track Record
1 year
#3,816 of 5,861 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,839+28.4%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 28.2% of fund✓ well diversified
Exxon Mobil Corp
4.1%
Johnson & Johnson
3.9%
Merck & Co Inc
3.1%
Alphabet Inc
3.0%
Verizon Communications Inc
2.7%
Chevron Corp
2.4%
Procter & Gamble Co/The
2.3%
Bank of America Corp
2.3%
Pfizer Inc
2.3%
Comcast Corp
2.1%
Asset allocation
Stocks
99.6%
Cash
0.4%
By sector
Financial Services
25.7%
Healthcare
17.4%
Technology
12.3%
Communication
11.3%
Consumer Cyclical
9.0%
Consumer Defensive
9.0%
Energy
8.8%
Industrials
4.6%
Other
1.9%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
10.9%Moderate
Year-on-year price swings
Max drawdown
-16.7%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks total return by investing primarily in U.S. value equities.
- Strategy
- Actively manages a portfolio of U.S. equities of value companies, using proprietary quantitative methods to identify those with positive return potential. Invests at least 80% of assets in companies tied economically to the U.S., considering market capitalization and sector exposure.
- Inception date
- October 28, 2024
- Fund family
- GMO
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at GMOV. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04